Urgent

Andersen-Tawil syndrome

Channelopathy · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Rare channelopathy with the triad of periodic paralysis, ventricular arrhythmias (prominent U waves, ventricular ectopy) and dysmorphic features.

Red flags

  • Sustained ventricular tachycardia
  • Syncope
  • Severe potassium swings
  • Respiratory involvement during paralysis

Assessment

Differential diagnosis

  • Long QT syndrome
  • Thyrotoxic periodic paralysis
  • Hypokalaemic periodic paralysis
  • CPVT
  • Hypokalaemia of other cause

Investigations

  • 12-lead ECG (prominent U waves, bidirectional/ventricular ectopy)
  • Serum potassium during episodes
  • Continuous telemetry
  • Thyroid function to exclude mimics
  • Genetic referral

Management

  • Continuous cardiac monitoring
  • Cautiously correct potassium disturbance during paralytic episodes
  • Treat sustained ventricular arrhythmia per ALS
  • Avoid QT-prolonging drugs
  • Refer to inherited cardiac conditions service
  • Manage recurrent paralysis with specialist input

Drugs & doses

Potassium replacement (guided by level and phase)
Beta-blocker or flecainide for arrhythmia (specialist)
Acetazolamide for paralysis (specialist)

Disposition

Admit for monitoring; specialist referral.

Complications & pitfalls

  • Ventricular arrhythmia
  • Recurrent paralysis / falls
  • Cardiac arrest (uncommon)

Exam pearls

  • Ventricular ectopy is frequent but often better tolerated than in other channelopathies.
  • Potassium level may be high, low or normal during paralytic attacks.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.